Healthcare

Technologies Enabling Next Generation Vaccine Development

Upcoming Vaccine Technologies for Infectious Diseases

INDUSTRY
Healthcare

RELEASE DATE
02-May-2019
REGION
Global
DELIVERABLE TYPE
Technology Research

RESEARCH CODE
D8AB-01-00-00-00
SKU
HC03170-GL-TR_23102
Yes
SHARE

Technologies Enabling Next Generation Vaccine Development
Published on: 02-May-2019 | SKU: HC03170-GL-TR_23102

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

Vaccine Delivery platforms: This section covers various nanoparticle-based vaccine delivery platforms such as nanoparticles of biological (self-assembling proteins) and non-biological origin ( inorganic and polymeric). The biological nanoparticles subsection overlaps with virus-like particles that has been separately addressed.

Virus-Like Particles: Virus-Like Particles are biological nanoparticles having size of around 20-100 nm. Due to the repetitive nature, viral capsid proteins have tendency to self-assemble. Lack of genetic material makes them non-replicative and hence safe vaccines. Therefore, VLPs are gaining a lot of attractions from vaccine development point of view.

Bacterial and fungal vaccines: This part discusses upcoming vaccines which can protect against multiple bacterial and fungal infections, toxoid vaccines, neutralizing antibodies and new technologies like carbohydrate-conjugate vaccines, surface antigen vaccines etc.

Synthetic vaccines: The segment of synthetic vaccines talks about the short, long and synthetic peptide vaccines against viral and bacterial diseases, innovative T cell stimulating immunogens and fusion proteins.

Viral vector-based vaccines: It covers genetically modified viral vectors which are engineered to make replication incompetent by deletion of essential genes or highly attenuated viral vectors that lack pathogenic genes.

Adjuvant technology: Unique lipid-based adjuvants, oil-in-water adjuvants, plant-derived adjuvants, synthetic and immune-cell-receptor based adjuvants as well as virosomes (derived from viral proteins) are reviewed here.

Vaccine synthesis, formulation and delivery platforms: This section partially overlaps with virus-based vaccine delivery platforms like virosomes, synthetic and modified-viral platforms, cell-free protein synthesis and gene delivery methods and proprietary cell lines used for vaccine production.

1.1 Research Scope: Vaccine Technologies Under Development Phase

1.2 Analysis Framework: Frost & Sullivan Core Value

1.3 Research Methodology: Five Steps Toward Success

1.4 Key Findings of Global Vaccine Technology Development

2.1 Research Scope: Current Status and Challenges of Vaccine Development

2.2 Technologies Transforming Next-generation Vaccines

3.1 Nanoparticles Enable Efficient and Safe Vaccine Delivery

3.2 Self-assembling Nanoparticles of Biological Origin

3.3 Polymeric and Inorganic Nanoparticles for Vaccine Delivery

4.1 Virus-like Particles Mimic The Real Viral Infection

4.2 Landscape of VLP-based Vaccines, Global, 2019

4.3 Influenza Shares A Major Portion of VLP-based Vaccines

4.4 Multiple Adaptations of VLP Technology for Vaccine Development

4.5 Plant Leaves Producing A Wide Variety of VLPs

5.1 Emerging Technologies for Bacterial and Fungal Vaccines

5.2 Emerging Bacterial and Fungal Vaccines, Global, 2019

5.3 New Strategies for Bacterial and Fungal Vaccines

5.4 Novel Vaccines & Therapeutics for Emerging Infectious Diseases

5.5 Multi-protein Complex-based Bacterial Vaccines

5.6 Carbohydrates-based or Conjugate Vaccines

6.1 Development Status of Synthetic Vaccines, Global, 2019

6.2 Peptides-based Vaccine Technologies

6.3 Genetically Modified Vaccines for HIV and Streptococci

7.1 Overview of Viral Vector-based Vaccines

7.2 Summary of Developing Viral Vector Vaccine Technology, Global, 2019

7.3 Diverse Replication-incompetent Viral Vaccines

7.4 Replication-incompetent Viruses with Nasal Spray Formulation

7.5 Live Attenuated Influenza Vaccines with Nasal Formulation

7.6 Viral Vector Vaccines for Serious Human Diseases

Flu vaccine based on regions of limited variability

8.1 Novel Lipid Formulations as Adjuvant

8.2 Oil-in-water Nanoemulsion and Saponin-based Adjuvants

8.3 Toll-like Receptor-based Adjuvants

9.1 Synopsis of Vaccine Synthesis, Formulation Delivery Platforms

9.2 Cell-free and Cell-based Vaccine Synthesis Platforms

9.3 Diverse Vaccine Formulation Technologies

9.4 Needle-less Solid Dose Vaccine Delivery Formulation and Device

9.5 Gold Nanoparticles and Applications in Vaccine Delivery

9.6 Nanopatch, Recombinant Protein and Lipid-based Carriers

10.1 Growth Opportunity 1: Influenza Vaccines

10.2 Growth Opportunity 2: Vaccines for Vector Borne Viral Diseases

10.3 Growth Opportunity 3: Vaccine Delivery Technologies

10.4 Strategic Imperatives for Success and Growth

11.1 Industry Interactions

Legal Disclaimer


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

17 Nov 2026   |   Global   |   Frost Radar

Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026

Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...

16 Nov 2026   |   North America   |   Frost Radar

Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026

This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...

03 Nov 2026   |   North America   |   Market Research

Enterprise Imaging Market, United States, 2025–2030

Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...

02 Nov 2026   |   Global   |   Market Research

Continuous Glucose Monitoring Market, Global, 2026

The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...

28 Oct 2026   |   Global   |   Frost Radar

Frost Radar™: Health Monitoring Wearable Solutions, 2026

The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.